ISSX 2012 18th North American Regional Meeting
Meeting - Dallas, Texas, U.S.A.
The Meeting aims to bring together many internationally renowned scientists and young scientists from academia and industry, working on drug/xenobiotic research in diverse fields including basic and clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal chemistry, drug discovery and development, molecular and structural biology and genetics, and other related areas.
The scientific program will include recent advances on the structure, function and regulation of drug metabolizing enzymes and transporters; omics based technologies for drug discovery and for drug/xenobiotic toxicity assessment; physiologic and/or toxicological roles of novel extrahepatic drug metabolizing enzymes; prediction and mechanisms of adverse drug reactions; environmental toxicology and health, and chemical carcinogenesis. Exciting sessions will be devoted to pharmacoepigenetic and microRNA dependent drug metabolism and action; toxicogenomics, a predictive tool in toxicology and drug development; epigenomics – impact for drug safety sciences; nutrition and cancer prevention; pharmacogenomics and cancer treatment; oxidative stress, DNA damage and repair and biological considerations. Contemporary issues in drug/xenobiotic research including bioengineering of new enzymes, nanotechnology and stem cell research will also be in the scientific program.
Sunday, October 14, 2012 to Thursday, October 18, 2012
Hilton Anatole Dallas Hotel, Dallas, Texas, U.S.A.
Contact: (information@issx.org)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
